drugset / Trial / NCT04957927

Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age

NCT04957927

RandomizedFactorialSingle-blindSupportive care

Summary

To determine the Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age.

Timeline

Start
2020-12-12
Primary completion
2021-09-12
Completion
2021-12-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified 50 ug Intranasal
Subject Montelukast Other / unclassified 4 mg Oral

Indications